ValiRx plc (LON:VAL – Get Free Report)’s stock price fell 12.8% on Monday . The company traded as low as GBX 0.53 ($0.01) and last traded at GBX 0.57 ($0.01). 9,117,890 shares were traded during mid-day trading, a decline of 22% from the average session volume of 11,719,508 shares. The stock had previously closed at GBX 0.65 ($0.01).
ValiRx Price Performance
The stock has a fifty day moving average of GBX 0.73 and a 200-day moving average of GBX 1.39. The firm has a market capitalization of £2.07 million, a P/E ratio of -0.37 and a beta of 0.59. The company has a quick ratio of 1.27, a current ratio of 6.65 and a debt-to-equity ratio of 0.44.
About ValiRx
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Featured Stories
- Five stocks we like better than ValiRx
- What Investors Need to Know to Beat the Market
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- Investing in Travel Stocks Benefits
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- Earnings Per Share Calculator: How to Calculate EPS
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
